Incidence and risk of hypertension with bevacizumab in non-small-cell lung cancer patients: a meta-analysis of randomized controlled trials

AIM: A study was conducted to determine the overall risk and incidence of hypertension with bevacizumab in non-small-cell lung cancer (NSCLC) patients. MATERIALS AND METHODS: Electronic databases such as the Embase, PubMed, and Cochrane Library were searched for related trials. Statistical analyses...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Drug Des Devel Ther
Asıl Yazarlar: Chen, Jian, Lu, Yingfeng, Zheng, Yunliang
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove Medical Press 2015
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4547635/
https://ncbi.nlm.nih.gov/pubmed/26316712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S87258
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller